Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective
Saved in:
| Published in: | ClinicoEconomics and Outcomes Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552935839891456 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | ClinicoEconomics and Outcomes Research |
| description | |
| discipline_display | Health and Safety |
| discipline_facet | Health and Safety |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:69267 |
| institution | FRELIP |
| journal_source_facet | ClinicoEconomics and Outcomes Research |
| last_indexed | 2026-06-20T21:29:00.958Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective Health and Safety General Health and Safety |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Health and Safety General Health and Safety |
| subject_facet | Health and Safety General Health and Safety |
| title | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective |
| title_alt | Semaglutida 2,4 mg para pacientes obesos con MASH: un análisis de costo-efectividad desde la perspectiva del NHS italiano Sémaglutide 2,4 mg pour les patients obèses atteints de stéatohépatite non alcoolique (MASH) : une analyse coût-efficacité du point de vue du NHS italien Semaglutida 2,4 mg para pacientes obesos com MASH: uma análise de custo-efetividade sob a perspectiva do NHS italiano |
| title_auth | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective |
| title_es_txt | Semaglutida 2,4 mg para pacientes obesos con MASH: un análisis de costo-efectividad desde la perspectiva del NHS italiano |
| title_fr_txt | Sémaglutide 2,4 mg pour les patients obèses atteints de stéatohépatite non alcoolique (MASH) : une analyse coût-efficacité du point de vue du NHS italien |
| title_full | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective |
| title_fullStr | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective |
| title_full_unstemmed | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective |
| title_pt_txt | Semaglutida 2,4 mg para pacientes obesos com MASH: uma análise de custo-efetividade sob a perspectiva do NHS italiano |
| title_short | Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspective |
| title_sort | semaglutide 2.4 mg for obese patients with mash: a cost-effectiveness analysis from the italian nhs perspective |
| topic | Health and Safety General Health and Safety |
| url | https://www.dovepress.com/semaglutide-24-mg-for-obese-patients-with-mash-a-cost-effectiveness-an-peer-reviewed-fulltext-article-CEOR |